What does Centre Médical d’Expertise Dr. WATRIN do?

Centre Médical d’Expertise Dr. WATRIN is a specialist medical practice in Fernelmont. Private Limited, started on 17 April 2012, 1 establishment.

What is the address of Centre Médical d’Expertise Dr. WATRIN?

The registered office of Centre Médical d’Expertise Dr. WATRIN is located at Rue des Prisonniers, Hing. 20, 5380 Fernelmont.

Is Centre Médical d’Expertise Dr. WATRIN still active?

Yes. According to the CBE (19 September 2026) Centre Médical d’Expertise Dr. WATRIN is active, legal situation “Normale toestand”, started on 17 April 2012.

Is Centre Médical d’Expertise Dr. WATRIN registered on Peppol?

Yes, Centre Médical d’Expertise Dr. WATRIN is registered on the Peppol network with ID 0208:0845310359.

What is the enterprise number of Centre Médical d’Expertise Dr. WATRIN?

The enterprise number of Centre Médical d’Expertise Dr. WATRIN is BE0845310359.

When was Centre Médical d’Expertise Dr. WATRIN founded?

Centre Médical d’Expertise Dr. WATRIN was founded on 17 April 2012.

Who are the directors of Centre Médical d’Expertise Dr. WATRIN?

According to the 2025 annual accounts, the directors of Centre Médical d’Expertise Dr. WATRIN are: Pierre-Paul WATRIN.

Is Centre Médical d’Expertise Dr. WATRIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 April 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Centre Médical d’Expertise Dr. WATRIN make in 2025?

Centre Médical d’Expertise Dr. WATRIN posted a profit after taxes of € 15,847 in financial year 2025.

What is the revenue of Centre Médical d’Expertise Dr. WATRIN?

As a small company, Centre Médical d’Expertise Dr. WATRIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 26,580.

Centre Médical d’Expertise Dr. WATRIN (Private Limited)

Dossier Centre Médical d’Expertise Dr. WATRIN, printed on 19 September 2026 from databakkes.be/en/0845310359/centre-medical-d-expertise-dr-watrin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Centre Médical d’Expertise Dr. WATRIN from Fernelmont, company number BE0845310359, closed financial year 2025 with a result of € 15,847 after tax. For that financial year Centre Médical d’Expertise Dr. WATRIN recorded a gross margin of € 26,580 and equity of € 128,164. Compared with financial year 2024, the result moved from € 24,031 to € 15,847. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Growing

€ 128,164

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 15,847

▼ 34% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 95,074

▲ 181% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 10,000 paid out

63 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,014

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,939

▲ 164% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,114

▲ 68% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 25,459 Gross margin 2022: € 25,459 First fiscal year in the series	€ 13,163 Gross margin 2023: € 13,163 ▼ 48% vs 2022 (€ 25,459) Unfavourable step	€ 38,924 Gross margin 2024: € 38,924 ▲ 196% vs 2023 (€ 13,163) Favourable step	€ 26,580 Gross margin 2025: € 26,580 ▼ 32% vs 2024 (€ 38,924) Unfavourable step	▼ 32%
Profit after taxes	€ 17,472 Profit after taxes 2022: € 17,472 First fiscal year in the series	€ 5,404 Profit after taxes 2023: € 5,404 ▼ 69% vs 2022 (€ 17,472) Unfavourable step	€ 24,031 Profit after taxes 2024: € 24,031 ▲ € 18,627 vs 2023 (€ 5,404) Favourable step	€ 15,847 Profit after taxes 2025: € 15,847 ▼ 34% vs 2024 (€ 24,031) Unfavourable step	▼ 34%
Equity	€ 103,242 Equity 2022: € 103,242 First fiscal year in the series	€ 106,046 Equity 2023: € 106,046 ▲ 3% vs 2022 (€ 103,242) Favourable step	€ 122,318 Equity 2024: € 122,318 ▲ 15% vs 2023 (€ 106,046) Favourable step	€ 128,164 Equity 2025: € 128,164 ▲ 5% vs 2024 (€ 122,318) Favourable step	▲ 5%
Total debts	€ 20,620 Total debts 2022: € 20,620 First fiscal year in the series	€ 11,757 Total debts 2023: € 11,757 ▼ 43% vs 2022 (€ 20,620) Favourable step	€ 18,722 Total debts 2024: € 18,722 ▲ 59% vs 2023 (€ 11,757) Unfavourable step	€ 26,369 Total debts 2025: € 26,369 ▲ 41% vs 2024 (€ 18,722) Unfavourable step	▲ 41%
Cash	€ 97,816 Cash 2022: € 97,816 First fiscal year in the series	€ 101,988 Cash 2023: € 101,988 ▲ 4% vs 2022 (€ 97,816) Favourable step	€ 33,783 Cash 2024: € 33,783 ▼ 67% vs 2023 (€ 101,988) Unfavourable step	€ 95,074 Cash 2025: € 95,074 ▲ 181% vs 2024 (€ 33,783) Favourable step	▲ 181%
Retained profit	€ 97,042 Retained profit 2022: € 97,042 First fiscal year in the series	€ 99,846 Retained profit 2023: € 99,846 ▲ 3% vs 2022 (€ 97,042) Favourable step	€ 116,118 Retained profit 2024: € 116,118 ▲ 16% vs 2023 (€ 99,846) Favourable step	€ 121,964 Retained profit 2025: € 121,964 ▲ 5% vs 2024 (€ 116,118) Favourable step	▲ 5%
Dividend	€ 3,800 Dividend 2022: € 3,800 First fiscal year in the series	€ 2,600 Dividend 2023: € 2,600 ▼ 32% vs 2022 (€ 3,800) Unchanged	€ 7,759 Dividend 2024: € 7,759 ▲ 198% vs 2023 (€ 2,600) Unchanged	€ 10,000 Dividend 2025: € 10,000 ▲ 29% vs 2024 (€ 7,759) Unchanged	▲ 29%
Balance sheet total	€ 123,862 Balance sheet total 2022: € 123,862 First fiscal year in the series	€ 117,804 Balance sheet total 2023: € 117,804 ▼ 5% vs 2022 (€ 123,862) Unchanged	€ 141,039 Balance sheet total 2024: € 141,039 ▲ 20% vs 2023 (€ 117,804) Unchanged	€ 154,533 Balance sheet total 2025: € 154,533 ▲ 10% vs 2024 (€ 141,039) Unchanged	▲ 10%

Key figures of Centre Médical d’Expertise Dr. WATRIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Centre Médical d’Expertise Dr. WATRIN?

What happened at Centre Médical d’Expertise Dr. WATRIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 17, 2026 New annual accounts for financial year 2025: profit of € 15,847 (▼ 34% vs 2024). Source: NBB ↗
May 7, 2012 New establishment in Namur. KBO
Apr 17, 2012 Start of the company according to the CBE. KBO
2011 Pierre-Paul WATRIN became a director. NBB

In short

From € 17,472 profit in 2022 to € 15,847 profit in 2025.

Paid € 26,685 in corporate taxes since 2022.

Best year ever: 2024, with € 24,031 profit.

Paid out € 24,159 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Centre Médical d’Expertise Dr. WATRIN? We notify you, reason included.

Follow Centre Médical d’Expertise Dr. WATRIN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Pierre-Paul WATRIN

Centre Médical d’Expertise Dr. WATRIN

Behind Centre Médical d’Expertise Dr. WATRIN is Pierre-Paul WATRIN.

See the full network in the app

Directors

According to the 2025 annual accounts

Pierre-Paul WATRIN

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Prisonniers, Hing. 20

5380 Fernelmont

2.209.031.082

Rue d'Harscamp 14

5000 Namur

Active since 7 May 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0845.310.359
VAT number: BE 0845.310.359
Registered office: Rue des Prisonniers, Hing. 20, 5380 Fernelmont
Names & denominations: Centre Médical d’Expertise Dr. WATRIN · CEMEDEX Dr.WATRIN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 April 2012
Peppol: Active · Active since 16 Dec 2024
Contact: 081225922
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗